About My Health Careers Internship MedBlogs Contact us

Breakthrough in Treating Irreversible Liver Cirrhosis

by Hannah Punitha on August 24, 2008 at 3:47 PM
Font : A-A+

 Breakthrough in Treating Irreversible Liver Cirrhosis

Researchers at Cold Spring Harbor Laboratory (CSHL) have found that a stable form of cell-cycle arrest, known to offer potent protection against cancer, also limits liver fibrosis - a condition characterized by an excess of fibrous tissue.

Liver fibrosis, triggered by chronic liver damage produced by hepatitis infection, alcohol abuse, or fatty liver disease, can lead to cirrhosis, a major health problem worldwide.


According to researchers, the new findings may have important implications for treating cirrhosis, a disease now considered to be irreversible. It could offer new insight into other disease states as well.

"Fibrosis is a disease of many organs-lungs, kidneys, pancreas, prostate, skin. It's possible this mechanism in the liver is relevant to fibrotic situations in other tissues," said Valery Krizhanovsky of Cold Spring Harbor Laboratory.

Krizhanovsky said that the state of cell-cycle arrest known as senescence was first described decades ago, but the phenomenon was thought to occur only in cultured cells in the laboratory.

More recent studies found that cellular senescence helps protect against the formation of tumors and aids in the response to certain anticancer agents.

To study the potential role of senescence in liver cirrhosis, the researchers examined mice treated with a liver-damaging agent.

They found that senescent cells accumulated in the livers of the mice, derived primarily from activated stellate cells.

Stellate cells are those that initially proliferate in response to liver damage and are responsible for producing the extracellular matrix, a kind of structural support for cells that is the hallmark of fibrotic scars.

"Once a lot of extracellular matrix has formed, it's very hard to clear. The material just sits there and creates an inflammatory environment," Krizhanovsky said.

However, their new findings offer some hope. The senescent stellate cells showed signs of reduced secretion of extracellular matrix components, enhanced secretion of enzymes that degrade extracellular matrix, and enhanced immune surveillance.

They found that accordingly natural killer cells preferentially target senescent-activated stellate cells both in cell culture and in living animals, helping to resolve fibrosis.

On contrary, stellate cells continued to divide in mice lacking key components of the senescence program, leading to excessive liver fibrosis.

The results suggest that immunostimulatory therapies might enhance senescent cell clearance and should be tested for the potential treatment of patients with liver fibrosis, especially in its early stages or following short-term exposure to liver toxins.

The study is published in the August 22nd Cell, a Cell Press publication.

Source: ANI

News A-Z
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Alcoholic Liver Disease Hepatitis A Bubbles and Brews - Alcohol Facts Liver Wilson's Disease Milk Thistle Current Treatments for Liver Cancer Fatty Liver Disease: A Growing Health Problem in India Living Donor Liver Transplant: What Are the Risks? Liver Cirrhosis 

Recommended Reading
Hepatitis A
Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. ....
Hepatitis B
Hepatitis B is inflammation of the liver due to infection with the hepatitis B virus....
Alcoholic Liver Disease
Encyclopedia section of medindia gives general information about Alcoholic Liver Disease....
Bubbles and Brews - Alcohol Facts
There is more to alcohol than mere intoxication. Infamous because of its social abuse but indispensa...
Current Treatments for Liver Cancer
Current Treatments for Liver Cancer (also known as hepatoma or hepatocellular carcinoma) can result ...
Fatty Liver Disease: A Growing Health Problem in India
Non alcoholic fatty liver disease (NAFLD) is the leading cause of liver dysfunction worldwide and is...
Liver Cirrhosis
Liver cirrhosis is a chronic liver disease that arises due to alcoholism, hepatitis, or other condit...
Living Donor Liver Transplant: What Are the Risks?
The risk of dying as a result of a living donor liver segment removal is between 0.2-2.0%. The risk ...
Milk Thistle
Milk Thistle is a resourceful natural plant which has many medicinal benefits. In herbal medication ...
Wilson's Disease
This is a rare inherited systemic disorder of copper metabolism, affecting the liver mainly before o...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use